Smith Nephew Plc Stock EBITDA

SNNUF Stock  USD 12.92  0.00  0.00%   
Smith Nephew plc fundamentals help investors to digest information that contributes to Smith Nephew's financial success or failures. It also enables traders to predict the movement of Smith Pink Sheet. The fundamental analysis module provides a way to measure Smith Nephew's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Smith Nephew pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Smith Nephew plc Company EBITDA Analysis

Smith Nephew's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

 = 

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Smith Nephew EBITDA

    
  1.25 B  
Most of Smith Nephew's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Smith Nephew plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition

According to the company disclosure, Smith Nephew plc reported earnings before interest,tax, depreciation and amortization of 1.25 B. This is 42.12% higher than that of the Healthcare sector and 94.08% higher than that of the Medical Devices industry. The ebitda for all United States stocks is 68.01% higher than that of the company.

Smith EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Smith Nephew's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Smith Nephew could also be used in its relative valuation, which is a method of valuing Smith Nephew by comparing valuation metrics of similar companies.
Smith Nephew is currently under evaluation in ebitda category among its peers.

Smith Fundamentals

About Smith Nephew Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Smith Nephew plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Smith Nephew using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Smith Nephew plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Smith Pink Sheet

Smith Nephew financial ratios help investors to determine whether Smith Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Smith with respect to the benefits of owning Smith Nephew security.